Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized，Controlled，Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of ZVS101e Administered as a Single Subretinal Injection in Subjects With Bietti's Crystalline Dystrophy (BCD)

NCT06743646 is registered in ClinicalTrials.gov with Chigenovo Co., Ltd as lead sponsor.

NCT NCT06743646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06743646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized，Controlled，Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of ZVS101e Administered as a Single Subretinal Injection in Subjects With Bietti's Crystalline Dystrophy (BCD)
Lead sponsor
Chigenovo Co., Ltd
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 27, 2024
Completion date
June 30, 2030
Enrollment
62 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bietti crystalline corneoretinal dystrophy, bietti crystalline dystrophy